Multicentre, open label, randomised controlled trial comparing intermittent versus daily treatment for non-cavitary nodular/bronchiectatic <i>Mycobacterium avium</i> complex lung disease with rifampicin, ethambutol and clarithromycin (iREC): study protocol
Distribution of the number of citations over years.